Version 5.4
Bos taurus Protein: BT.22766
Summary
InnateDB Protein IDBP-687444.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.22766
Protein Name squamous cell carcinoma antigen recognized by T-cells 3
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000042572
InnateDB Gene IDBG-635596 (BT.22766)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 41 interaction(s) predicted by orthology.
Predicted by orthology
Total 41 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0000166 nucleotide binding
GO:0003676 nucleic acid binding
GO:0005515 protein binding
GO:0044822 poly(A) RNA binding
Biological Process
GO:0000902 cell morphogenesis
GO:0006396 RNA processing
GO:0010468 regulation of gene expression
GO:0048872 homeostasis of number of cells
GO:0071425 hematopoietic stem cell proliferation
Cellular Component
GO:0005622 intracellular
Protein Structure and Domains
PDB ID
InterPro IPR000504 RNA recognition motif domain
IPR003107 HAT (Half-A-TPR) repeat
IPR008669 LSM-interacting domain
PFAM PF00076
PF02184
PF05391
PRINTS
PIRSF
SMART SM00360
SM00386
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1N0I9
UniProt Splice Variant
Entrez Gene 505922
UniGene Bt.22766
RefSeq NP_001095330
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02045494
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca